Intellipharmaceutics International Inc. (IPCIF)

IPCIF Revenue

Intellipharmaceutics International had revenue of $904.95K in the twelve months ending August 31, 2023, with 386.82% growth year-over-year. Revenue in the quarter ending August 31, 2023 was $68.72K with 260.38% year-over-year growth. In the fiscal year ending November 30, 2022, Intellipharmaceutics International had annual revenue of $65.73K.

• Revenue (ttm): $904.95K
• Revenue Growth: +386.82%
• P/S Ratio: 6.37
• Revenue / Employee: $82,268
• Employees: 11
• Market Cap: 5.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2022	65.73K	-	-
Nov 30, 2021	65.73K	-1.34M	-95.31%
Nov 30, 2020	1.40M	-	-
Nov 30, 2019	1.40M	-311.21K	-18.17%
Nov 30, 2018	1.71M	-3.79M	-68.88%
Nov 30, 2017	5.50M	3.26M	144.97%
Nov 30, 2016	2.25M	-1.85M	-45.11%
Nov 30, 2015	4.09M	-4.68M	-53.32%
Nov 30, 2014	8.77M	7.24M	474.13%
Nov 30, 2013	1.53M	1.42M	1,326.33%
Nov 30, 2012	107.09K	-394.72K	-78.66%
Nov 30, 2011	501.81K	-957.57K	-65.61%
Nov 30, 2010	1.46M	-	-
Nov 30, 2008	0	-	-
Nov 30, 2007	0	-	-
Nov 30, 2006	0	-	-
Nov 30, 2005	0	-	-
Nov 30, 2004	0	-	-
Nov 30, 2003	0	-	-
Nov 30, 2002	0	-	-
Nov 30, 2001	1.00K	0.21	0.02%
Nov 30, 2000	999.82	-99.06K	-99.00%
Nov 30, 1999	100.06K	221.19	0.22%
Nov 30, 1998	99.84K	29.56K	42.07%
Nov 30, 1997	70.27K	-3.94K	-5.31%
Nov 30, 1996	74.21K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.